Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury

Experimental Neurology

Volumn 258, Issue , 2014, Pages 62-77

  Bastien, Dominic ^a   Lacroix, Steve ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Interleukin 1; Macrophage; Nervous system; Neurodegeneration; Neuroimmunology; Neutrophil; Regeneration; Sciatic nerve; Wallerian degeneration

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ASTROCYTOSIS; CELL REGENERATION; CELL SURVIVAL; CYTOKINE RELEASE; GLIA CELL; GLIOSIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE FUNCTION; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

INTERLEUKIN-1; MACROPHAGE; NERVOUS SYSTEM; NEURODEGENERATION; NEUROIMMUNOLOGY; NEUTROPHIL; REGENERATION; SCIATIC NERVE; WALLERIAN DEGENERATION;

ANIMALS; CYTOKINES; HUMANS; LEUKOCYTES; NEUROGLIA; PERIPHERAL NERVE INJURIES; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 84904720898     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.006     Document Type: Review

References (269)

1. Ackery A., Robins S., Fehlings M.G. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J. Neurotrauma 2006, 23:604-616.
2. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
3. Afonina I.S., Tynan G.A., Logue S.E., Cullen S.P., Bots M., Luthi A.U., Reeves E.P., McElvaney N.G., Medema J.P., Lavelle E.C., Martin S.J. Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alpha. Mol. Cell 2011, 44:265-278.
4. Akhurst R.J. Large- and small-molecule inhibitors of transforming growth factor-beta signaling. Curr. Opin. Investig. Drugs 2006, 7:513-521.
5. Akhurst R.J., Hata A. Targeting the TGFbeta signalling pathway in disease. Nat. Rev. Drug Discov. 2012, 11:790-811.
6. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
7. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
8. Allen C., Thornton P., Denes A., McColl B.W., Pierozynski A., Monestier M., Pinteaux E., Rothwell N.J., Allan S.M. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J. Immunol. 2012, 189:381-392.
9. Andre R., Pinteaux E., Kimber I., Rothwell N.J. Differential actions of IL-1 alpha and IL-1 beta in glial cells share common IL-1 signalling pathways. Neuroreport 2005, 16:153-157.
10. Anforth H.R., Bluthe R.M., Bristow A., Hopkins S., Lenczowski M.J., Luheshi G., Lundkvist J., Michaud B., Mistry Y., Van Dam A.M., Zhen C., Dantzer R., Poole S., Rothwell N.J., Tilders F.J., Wollman E.E. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur. Cytokine Netw. 1998, 9:279-288.
11. Arend W.P., Palmer G., Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008, 223:20-38.
12. Attwell D., Buchan A.M., Charpak S., Lauritzen M., Macvicar B.A., Newman E.A. Glial and neuronal control of brain blood flow. Nature 2010, 468:232-243.
13. Babcock A.A., Wirenfeldt M., Holm T., Nielsen H.H., Dissing-Olesen L., Toft-Hansen H., Millward J.M., Landmann R., Rivest S., Finsen B., Owens T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 2006, 26:12826-12837.
14. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 1996, 16:2945-2955.
15. Balentine J.D. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab. Investig. 1978, 39:236-253.
16. Bao F., Liu D. Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: protection by a metalloporphyrin. Neuroscience 2004, 126:285-295.
17. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
18. Barrette B., Hebert M.A., Filali M., Lafortune K., Vallieres N., Gowing G., Julien J.P., Lacroix S. Requirement of myeloid cells for axon regeneration. J. Neurosci. 2008, 28:9363-9376.
19. Bartanusz V., Jezova D., Alajajian B., Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann. Neurol. 2011, 70:194-206.
20. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422-1438.
21. Basu A., Krady J.K., Enterline J.R., Levison S.W. Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 2002, 40:109-120.
22. Basu A., Krady J.K., O'Malley M., Styren S.D., DeKosky S.T., Levison S.W. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J. Neurosci. 2002, 22:6071-6082.
23. Basu A., Krady J.K., Levison S.W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 2004, 78:151-156.
24. Beck K.D., Nguyen H.X., Galvan M.D., Salazar D.L., Woodruff T.M., Anderson A.J. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 2010, 133:433-447.
25. Bedard A., Tremblay P., Chernomoretz A., Vallieres L. Identification of genes preferentially expressed by microglia and upregulated during cuprizone-induced inflammation. Glia 2007, 55:777-789.
26. Be'eri H., Reichert F., Saada A., Rotshenker S. The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur. J. Neurosci. 1998, 10:2707-2713.
27. Benton R.L., Maddie M.A., Minnillo D.R., Hagg T., Whittemore S.R. Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse. J. Comp. Neurol. 2008, 507:1031-1052.
28. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
29. Beyrau M., Bodkin J.V., Nourshargh S. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol. 2012, 2:120134.
30. Blight A.R. Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 1985, 2:299-315.
31. Blight A.R. Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage. Neuroscience 1994, 60:263-273.
32. Boivin A., Pineau I., Barrette B., Filali M., Vallieres N., Rivest S., Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 2007, 27:12565-12576.
33. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., Rothwell N.J. Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 2001, 21:5528-5534.
34. Boven L.A., Van Meurs M., Van Zwam M., Wierenga-Wolf A., Hintzen R.Q., Boot R.G., Aerts J.M., Amor S., Nieuwenhuis E.E., Laman J.D. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
35. Bradke F., Fawcett J.W., Spira M.E. Assembly of a new growth cone after axotomy: the precursor to axon regeneration. Nat. Rev. Neurosci. 2012, 13:183-193.
36. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 2005, 202:145-156.
37. Brambilla R., Hurtado A., Persaud T., Esham K., Pearse D.D., Oudega M., Bethea J.R. Transgenic inhibition of astroglial NF-kappaB leads to increased axonal sparing and sprouting following spinal cord injury. J. Neurochem. 2009, 110:765-778.
38. Brewer K.L., Bethea J.R., Yezierski R.P. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 1999, 159:484-493.
39. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-e339.
40. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2:788-794.
41. Burda J.E., Sofroniew M.V. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 2014, 81:229-248.
42. Buryskova M., Pospisek M., Grothey A., Simmet T., Burysek L. Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J. Biol. Chem. 2004, 279:4017-4026.
43. Busch S.A., Horn K.P., Silver D.J., Silver J. Overcoming macrophage-mediated axonal dieback following CNS injury. J. Neurosci. 2009, 29:9967-9976.
44. Buss A., Pech K., Kakulas B.A., Martin D., Schoenen J., Noth J., Brook G.A. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord 2008, 46:364-371.
45. Cabal-Hierro L., Lazo P.S. Signal transduction by tumor necrosis factor receptors. Cell. Signal. 2012, 24:1297-1305.
46. Cafferty W.B., Gardiner N.J., Das P., Qiu J., McMahon S.B., Thompson S.W. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J. Neurosci. 2004, 24:4432-4443.
47. Cao Z., Gao Y., Bryson J.B., Hou J., Chaudhry N., Siddiq M., Martinez J., Spencer T., Carmel J., Hart R.B., Filbin M.T. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J. Neurosci. 2006, 26:5565-5573.
48. Carruth L.M., Demczuk S., Mizel S.B. Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J. Biol. Chem. 1991, 266:12162-12167.
49. Casella G.T., Bunge M.B., Wood P.M. Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp. Neurol. 2006, 202:8-20.
50. Casha S., Yu W.R., Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001, 103:203-218.
51. Casha S., Yu W.R., Fehlings M.G. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp. Neurol. 2005, 196:390-400.
52. Chan J.K., Roth J., Oppenheim J.J., Tracey K.J., Vogl T., Feldmann M., Horwood N., Nanchahal J. Alarmins: awaiting a clinical response. J. Clin. Invest. 2012, 122:2711-2719.
53. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 2007, 13:851-856.
54. Chen K.B., Uchida K., Nakajima H., Yayama T., Hirai T., Watanabe S., Guerrero A.R., Kobayashi S., Ma W.Y., Liu S.Y., Baba H. Tumor necrosis factor-alpha antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Phila Pa 1976) 2011, 36:1350-1358.
55. Chi L.Y., Yu J., Zhu H., Li X.G., Zhu S.G., Kindy M.S. The dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury. Neurosci. Lett. 2008, 438:174-179.
56. Cohen I., Rider P., Carmi Y., Braiman A., Dotan S., White M.R., Voronov E., Martin M.U., Dinarello C.A., Apte R.N. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2574-2579.
57. Cregg J.M., Depaul M.A., Filous A.R., Lang B.T., Tran A., Silver J. Functional regeneration beyond the glial scar. Exp. Neurol. 2014, 253C:197-207.
58. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 1997, 3:73-76.
59. Davalos D., Grutzendler J., Yang G., Kim J.V., Zuo Y., Jung S., Littman D.R., Dustin M.L., Gan W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
60. Davalos D., Ryu J.K., Merlini M., Baeten K.M., Le Moan N., Petersen M.A., Deerinck T.J., Smirnoff D.S., Bedard C., Hakozaki H., Gonias Murray S., Ling J.B., Lassmann H., Degen J.L., Ellisman M.H., Akassoglou K. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 2012, 3:1227.
61. David S., Aguayo A.J. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science 1981, 214:931-933.
62. David S., Kroner A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 2011, 12:388-399.
63. David S., Lacroix S. Role of the immune response in tissue damage and repair in the injured spinal cord. Clinical Neuroimmunology 2005, 53-63. Oxford University press, New York. Second edition. J. Antel, G. Birnbaum, H.P. Hartung, A. Vincent (Eds.).
64. de Rivero Vaccari J.P., Lotocki G., Marcillo A.E., Dietrich W.D., Keane R.W. A molecular platform in neurons regulates inflammation after spinal cord injury. J. Neurosci. 2008, 28:3404-3414.
65. de Rivero Vaccari J.P., Bastien D., Yurcisin G., Pineau I., Dietrich W.D., De Koninck Y., Keane R.W., Lacroix S. P2X4 receptors influence inflammasome activation following spinal cord injury. J. Neurosci. 2012, 32:3058-3066.
66. Denny M.F., Yalavarthi S., Zhao W., Thacker S.G., Anderson M., Sandy A.R., McCune W.J., Kaplan M.J. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 2010, 184:3284-3297.
67. Dibaj P., Nadrigny F., Steffens H., Scheller A., Hirrlinger J., Schomburg E.D., Neusch C., Kirchhoff F. NO mediates microglial response to acute spinal cord injury under ATP control in vivo. Glia 2010, 58:1133-1144.
68. Dibaj P., Steffens H., Zschuntzsch J., Nadrigny F., Schomburg E.D., Kirchhoff F., Neusch C. In vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS. PLoS One 2011, 6:e17910.
69. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood 1991, 77:1627-1652.
70. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
71. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
72. Dinarello C.A., Simon A., van der Meer J.W. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 2012, 11:633-652.
73. Dohrmann G.J., Wagner F.C., Bucy P.C. The microvasculature in transitory traumatic paraplegia. An electron microscopic study in the monkey. J. Neurosurg. 1971, 35:263-271.
74. Donnelly D.J., Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp. Neurol. 2008, 209:378-388.
75. Donnelly D.J., Longbrake E.E., Shawler T.M., Kigerl K.A., Lai W., Tovar C.A., Ransohoff R.M., Popovich P.G. Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+macrophages. J. Neurosci. 2011, 31:9910-9922.
76. Dray C., Rougon G., Debarbieux F. Quantitative analysis by in vivo imaging of the dynamics of vascular and axonal networks in injured mouse spinal cord. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9459-9464.
77. Eigenbrod T., Park J.H., Harder J., Iwakura Y., Nunez G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J. Immunol. 2008, 181:8194-8198.
78. Evans T.A., Barkauskas D.S., Myers J., Hare E.G., You J., Ransohoff R.M., Huang A.Y., Silver J. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp. Neurol. 2014, 254:109-120.
79. Farrar M.J., Bernstein I.M., Schlafer D.H., Cleland T.A., Fetcho J.R., Schaffer C.B. Chronic in vivo imaging in the mouse spinal cord using an implanted chamber. Nat. Methods. 2012, 9:297-302.
80. Fassbender J.M., Whittemore S.R., Hagg T. Targeting microvasculature for neuroprotection after SCI. Neurotherapeutics 2011, 8:240-251.
81. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B., Sofroniew M.V. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 2004, 24:2143-2155.
82. Fenrich K.K., Weber P., Hocine M., Zalc M., Rougon G., Debarbieux F. Long-term in vivo imaging of normal and pathological mouse spinal cord with subcellular resolution using implanted glass windows. J. Physiol. 2012, 590:3665-3675.
83. Fernandez-Valle C., Bunge R.P., Bunge M.B. Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration. J. Neurocytol. 1995, 24:667-679.
84. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
85. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 2010, 10:554-567.
86. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 2006, 129:3249-3269.
87. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat. Immunol. 2009, 10:241-247.
88. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
89. Fu S.Y., Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol. Neurobiol. 1997, 14:67-116.
90. Fuchs A.C., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Radwanski E., Affrime M.B., Cutler D.L., Grint P.C., Dinarello C.A. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 1996, 16:291-303.
91. Fujiki M., Zhang Z., Guth L., Steward O. Genetic influences on cellular reactions to spinal cord injury: activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration. J. Comp. Neurol. 1996, 371:469-484.
92. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
93. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Esposito E., Bramanti P., Cuzzocrea S. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008, 29:32-41.
94. Genovese T., Esposito E., Mazzon E., Di Paola R., Caminiti R., Bramanti P., Cappelani A., Cuzzocrea S. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J. Neurochem. 2009, 108:1360-1372.
95. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp. Neurol. 1994, 129:225-236.
96. Geremia N.M., Bao F., Rosenzweig T.E., Hryciw T., Weaver L., Dekaban G.A., Brown A. CD11d antibody treatment improves recovery in spinal cord-injured mice. J. Neurotrauma 2012, 29:539-550.
97. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997, 386:619-623.
98. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., Samokhvalov I.M., Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
99. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
100. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
101. Graves B.J., Hatada M.H., Hendrickson W.A., Miller J.K., Madison V.S., Satow Y. Structure of interleukin 1 alpha at 2.7-A resolution. Biochemistry 1990, 29:2679-2684.
102. Gray M., Palispis W., Popovich P.G., van Rooijen N., Gupta R. Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J. Neurosci. Res. 2007, 85:766-777.
103. Greenhalgh A.D., Galea J., Denes A., Tyrrell P.J., Rothwell N.J. Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection. Br. J. Pharmacol. 2010, 160:153-159.
104. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
105. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997, 275:206-209.
106. Guerrero A.R., Uchida K., Nakajima H., Watanabe S., Nakamura M., Johnson W.E., Baba H. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J. Neuroinflammation 2012, 9:40.
107. Hains B.C., Yucra J.A., Hulsebosch C.E. Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J. Neurotrauma 2001, 18:409-423.
108. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
109. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 2011, 12:778-785.
110. Hanna R.N., Shaked I., Hubbeling H.G., Punt J.A., Wu R., Herrley E., Zaugg C., Pei H., Geissmann F., Ley K., Hedrick C.C. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res. 2012, 110:416-427.
111. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
112. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
113. Hellal F., Hurtado A., Ruschel J., Flynn K.C., Laskowski C.J., Umlauf M., Kapitein L.C., Strikis D., Lemmon V., Bixby J., Hoogenraad C.C., Bradke F. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science 2011, 331:928-931.
114. Herrmann J.E., Imura T., Song B., Qi J., Ao Y., Nguyen T.K., Korsak R.A., Takeda K., Akira S., Sofroniew M.V. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J. Neurosci. 2008, 28:7231-7243.
115. Herx L.M., Rivest S., Yong V.W. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 2000, 165:2232-2239.
116. Hirata K., Kawabuchi M. Myelin phagocytosis by macrophages and nonmacrophages during Wallerian degeneration. Microsc. Res. Tech. 2002, 57:541-547.
117. Horn K.P., Busch S.A., Hawthorne A.L., van Rooijen N., Silver J. Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J. Neurosci. 2008, 28:9330-9341.
118. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
119. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 2006, 109:210-226.
120. John G.R., Lee S.C., Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 2003, 9:10-22.
121. John G.R., Lee S.C., Song X., Rivieccio M., Brosnan C.F. IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 2005, 49:161-176.
122. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
123. Kanda T. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies. J. Neurol. Neurosurg. Psychiatry 2013, 84:208-212.
124. Karanth S., Yang G., Yeh J., Richardson P.M. Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp. Neurol. 2006, 202:161-166.
125. Karkkainen I., Rybnikova E., Pelto-Huikko M., Huovila A.P. Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell. Neurosci. 2000, 15:547-560.
126. Kerschensteiner M., Schwab M.E., Lichtman J.W., Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat. Med. 2005, 11:572-577.
127. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., Wieghofer P., Heinrich A., Riemke P., Holscher C., Muller D.N., Luckow B., Brocker T., Debowski K., Fritz G., Opdenakker G., Diefenbach A., Biber K., Heikenwalder M., Geissmann F., Rosenbauer F., Prinz M. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 2013, 16:273-280.
128. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoska A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
129. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
130. Kigerl Kristina A., de Rivero Vaccari Juan Pablo, Dietrich W.Dalton, Popovich Phillip G., Keane Robert W. Pattern recognition receptors and central nervous system repair. Exp. Neurol. 2014, 258:5-16. (in this issue).
131. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153:143-151.
132. Knoferle J., Koch J.C., Ostendorf T., Michel U., Planchamp V., Vutova P., Tonges L., Stadelmann C., Bruck W., Bahr M., Lingor P. Mechanisms of acute axonal degeneration in the optic nerve in vivo. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6064-6069.
133. Kobayashi Y., Yamamoto K., Saido T., Kawasaki H., Oppenheim J.J., Matsushima K. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5548-5552.
134. Kohta M., Kohmura E., Yamashita T. Inhibition of TGF-beta1 promotes functional recovery after spinal cord injury. Neurosci. Res. 2009, 65:393-401.
135. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 2005, 162:71-80.
136. Kwon B.K., Okon E., Hillyer J., Mann C., Baptiste D., Weaver L.C., Fehlings M.G., Tetzlaff W. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J. Neurotrauma 2011, 28:1545-1588.
137. Lacroix S., Chang L., Rose-John S., Tuszynski M.H. Delivery of Hyper-IL-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 2002, 454:213-228.
138. Lagord C., Berry M., Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol. Cell. Neurosci. 2002, 20:69-92.
139. Lambertsen K.L., Clausen B.H., Babcock A.A., Gregersen R., Fenger C., Nielsen H.H., Haugaard L.S., Wirenfeldt M., Nielsen M., Dagnaes-Hansen F., Bluethmann H., Faergeman N.J., Meldgaard M., Deierborg T., Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 2009, 29:1319-1330.
140. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
141. Laping N.J., Morgan T.E., Nichols N.R., Rozovsky I., Young-Chan C.S., Zarow C., Finch C.E. Transforming growth factor-beta 1 induces neuronal and astrocyte genes: tubulin alpha 1, glial fibrillary acidic protein and clusterin. Neuroscience 1994, 58:563-572.
142. Lee H., Jo E.K., Choi S.Y., Oh S.B., Park K., Kim J.S., Lee S.J. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem. Biophys. Res. Commun. 2006, 350:742-747.
143. Lee S.M., Rosen S., Weinstein P., van Rooijen N., Noble-Haeusslein L.J. Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J. Neurotrauma 2011, 28:1893-1907.
144. Lee J.Y., Kim H.S., Choi H.Y., Oh T.H., Ju B.G., Yune T.Y. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury. J. Neurochem. 2012, 121:818-829.
145. Lee J.Y., Kim H.S., Choi H.Y., Oh T.H., Yune T.Y. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain 2012, 135:2375-2389.
146. Letellier E., Kumar S., Sancho-Martinez I., Krauth S., Funke-Kaiser A., Laudenklos S., Konecki K., Klussmann S., Corsini N.S., Kleber S., Drost N., Neumann A., Levi-Strauss M., Brors B., Gretz N., Edler L., Fischer C., Hill O., Thiemann M., Biglari B., Karray S., Martin-Villalba A. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 2010, 32:240-252.
147. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
148. Li M.O., Flavell R.A. TGF-beta: a master of all T cell trades. Cell 2008, 134:392-404.
149. Lin H.W., Basu A., Druckman C., Cicchese M., Krady J.K., Levison S.W. Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury. J. Neuroinflammation 2006, 3:15.
150. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., Hsu C.Y., Choi D.W. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 1997, 17:5395-5406.
151. Liu D., Sybert T.E., Qian H., Liu J. Superoxide production after spinal injury detected by microperfusion of cytochrome c. Free Radic. Biol. Med. 1998, 25:298-304.
152. Liu D., Ling X., Wen J., Liu J. The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J. Neurochem. 2000, 75:2144-2154.
153. Logan A., Berry M., Gonzalez A.M., Frautschy S.A., Sporn M.B., Baird A. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 1994, 6:355-363.
154. Logan A., Green J., Hunter A., Jackson R., Berry M. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur. J. Neurosci. 1999, 11:2367-2374.
155. Lotocki G., Alonso O.F., Dietrich W.D., Keane R.W. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. J. Neurosci. 2004, 24:11010-11016.
156. Luheshi N.M., Rothwell N.J., Brough D. Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br. J. Pharmacol. 2009, 157:1318-1329.
157. Luheshi N.M., Kovacs K.J., Lopez-Castejon G., Brough D., Denes A. Interleukin-1alpha expression precedes IL-1beta after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. J. Neuroinflammation 2011, 8:186.
158. Maikos J.T., Shreiber D.I. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J. Neurotrauma 2007, 24:492-507.
159. March C.J., Mosley B., Larsen A., Cerretti D.P., Braedt G., Price V., Gillis S., Henney C.S., Kronheim S.R., Grabstein K., et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985, 315:641-647.
160. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 2007, 7:31-40.
161. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
162. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
163. Mason J.L., Ye P., Suzuki K., D'Ercole A.J., Matsushima G.K. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 2000, 20:5703-5708.
164. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 2001, 21:7046-7052.
165. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 2000, 1:169-178.
166. Mautes A.E., Weinzierl M.R., Donovan F., Noble L.J. Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys. Ther. 2000, 80:673-687.
167. Mawhinney L.A., Thawer S.G., Lu W.Y., Rooijen N., Weaver L.C., Brown A., Dekaban G.A. Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J. Neuropathol. Exp. Neurol. 2012, 71:180-197.
168. McTigue D.M., Tripathi R.B. The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem. 2008, 107:1-19.
169. McTigue D.M., Popovich P.G., Morgan T.E., Stokes B.T. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp. Neurol. 2000, 163:220-230.
170. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
171. Miklossy J., Van der Loos H. The long-distance effects of brain lesions: visualization of myelinated pathways in the human brain using polarizing and fluorescence microscopy. J. Neuropathol. Exp. Neurol. 1991, 50:1-15.
172. Mildner A., Schmidt H., Nitsche M., Merkler D., Hanisch U.K., Mack M., Heikenwalder M., Bruck W., Priller J., Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 2007, 10:1544-1553.
173. Minkiewicz J., de Rivero Vaccari J.P., Keane R.W. Human astrocytes express a novel NLRP2 inflammasome. Glia 2013, 61:1113-1121.
174. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1218.
175. Miyoshi K., Obata K., Kondo T., Okamura H., Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J. Neurosci. 2008, 28:12775-12787.
176. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
177. Morgan T.E., Laping N.J., Rozovsky I., Oda T., Hogan T.H., Finch C.E., Pasinetti G.M. Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions. J. Neuroimmunol. 1995, 58:101-110.
178. Mosley B., Urdal D.L., Prickett K.S., Larsen A., Cosman D., Conlon P.J., Gillis S., Dower S.K. The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J. Biol. Chem. 1987, 262:2941-2944.
179. Muldoon L.L., Alvarez J.I., Begley D.J., Boado R.J., Del Zoppo G.J., Doolittle N.D., Engelhardt B., Hallenbeck J.M., Lonser R.R., Ohlfest J.R., Prat A., Scarpa M., Smeyne R.J., Drewes L.R., Neuwelt E.A. Immunologic privilege in the central nervous system and the blood-brain barrier. J. Cereb. Blood Flow Metab. 2013, 33:13-21.
180. Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993, 260:1808-1810.
181. Murinson B.B., Archer D.R., Li Y., Griffin J.W. Degeneration of myelinated efferent fibers prompts mitosis in Remak Schwann cells of uninjured C-fiber afferents. J. Neurosci. 2005, 25:1179-1187.
182. Nadeau S., Filali M., Zhang J., Kerr B.J., Rivest S., Soulet D., Iwakura Y., de Rivero Vaccari J.P., Keane R.W., Lacroix S. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1{beta} and TNF: implications for neuropathic pain. J. Neurosci. 2011, 31:12533-12542.
183. Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204:3037-3047.
184. Nakamura M., Okada S., Toyama Y., Okano H. Role of IL-6 in spinal cord injury in a mouse model. Clin. Rev. Allergy Immunol. 2005, 28:197-204.
185. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 2001, 19:423-474.
186. Nave K.A. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 2010, 11:275-283.
187. Nesic O., Xu G.Y., McAdoo D., High K.W., Hulsebosch C., Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J. Neurotrauma 2001, 18:947-956.
188. Nguyen L., Rothwell N.J., Pinteaux E., Boutin H. Contribution of interleukin-1 receptor accessory protein B to interleukin-1 actions in neuronal cells. Neurosignals 2011, 19:222-230.
189. Nikic I., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M., Bruck W., Bishop D., Misgeld T., Kerschensteiner M. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 2011, 17:495-499.
190. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
191. Noble L.J., Wrathall J.R. Blood-spinal cord barrier disruption proximal to a spinal cord transection in the rat: time course and pathways associated with protein leakage. Exp. Neurol. 1988, 99:567-578.
192. Noble L.J., Wrathall J.R. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp. Neurol. 1989, 103:34-40.
193. Noble L.J., Wrathall J.R. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 1989, 482:57-66.
194. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 2002, 22:7526-7535.
195. Okada S., Nakamura M., Mikami Y., Shimazaki T., Mihara M., Ohsugi Y., Iwamoto Y., Yoshizaki K., Kishimoto T., Toyama Y., Okano H. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J. Neurosci. Res. 2004, 76:265-276.
196. Okada S., Nakamura M., Katoh H., Miyao T., Shimazaki T., Ishii K., Yamane J., Yoshimura A., Iwamoto Y., Toyama Y., Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, 12:829-834.
197. O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: 10years of progress. Immunol. Rev. 2008, 226:10-18.
198. O'Neill L.A., Dinarello C.A. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today 2000, 21:206-209.
199. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
200. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., Hidalgo J. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 1999, 25:343-357.
201. Perrin F.E., Lacroix S., Aviles-Trigueros M., David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 2005, 128:854-866.
202. Pillay J., Ramakers B.P., Kamp V.M., Loi A.L., Lam S.W., Hietbrink F., Leenen L.P., Tool A.T., Pickkers P., Koenderman L. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J. Leukoc. Biol. 2010, 88:211-220.
203. Pillay J., Kamp V.M., van Hoffen E., Visser T., Tak T., Lammers J.W., Ulfman L.H., Leenen L.P., Pickkers P., Koenderman L. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 2012, 122:327-336.
204. Pineau I., Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 2007, 500:267-285.
205. Pineau I., Lacroix S. Endogenous signals initiating inflammation in the injured nervous system. Glia 2009, 57:351-361.
206. Pineau I., Libo S., Bastien D., Lacroix S. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 2010, 24:540-553.
207. Plunkett J.A., Yu C.G., Easton J.M., Bethea J.R., Yezierski R.P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 2001, 168:144-154.
208. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142:258-275.
209. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 1999, 158:351-365.
210. Pradillo J.M., Denes A., Greenhalgh A.D., Boutin H., Drake C., McColl B.W., Barton E., Proctor S.D., Russell J.C., Rothwell N.J., Allan S.M. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J. Cereb. Blood Flow Metab. 2012, 32:1810-1819.
211. Rabchevsky A.G., Streit W.J. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J. Neurosci. Res. 1997, 47:34-48.
212. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
213. Reichert F., Saada A., Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J. Neurosci. 1994, 14:3231-3245.
214. Rice T., Larsen J., Rivest S., Yong V.W. Characterization of the early neuroinflammation after spinal cord injury in mice. J. Neuropathol. Exp. Neurol. 2007, 66:184-195.
215. Rider P., Carmi Y., Guttman O., Braiman A., Cohen I., Voronov E., White M.R., Dinarello C.A., Apte R.N. IL-1{alpha} and IL-1{beta} recruit different myeloid cells and promote different stages of sterile inflammation. J. Immunol. 2011, 187:4835-4843.
216. Robins-Steele S., Nguyen D.H., Fehlings M.G. The delayed post-injury administration of soluble fas receptor attenuates post-traumatic neural degeneration and enhances functional recovery after traumatic cervical spinal cord injury. J. Neurotrauma 2012, 29:1586-1599.
217. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6:315-325.
218. Royall J.A., Berkow R.L., Beckman J.S., Cunningham M.K., Matalon S., Freeman B.A. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability. Am. J. Physiol. 1989, 257:L399-L410.
219. Sabat R. IL-10 family of cytokines. Cytokine Growth Factor Rev. 2010, 21:315-324.
220. Santello M., Volterra A. TNFalpha in synaptic function: switching gears. Trends Neurosci. 2012, 35:638-647.
221. Sato A., Ohtaki H., Tsumuraya T., Song D., Ohara K., Asano M., Iwakura Y., Atsumi T., Shioda S. Interleukin-1 participates in the classical and alternative activation of microglia/macrophages after spinal cord injury. J. Neuroinflammation 2012, 9:65.
222. Schmierer B., Hill C.S. TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 2007, 8:970-982.
223. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., Frampton J., Liu K.J., Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
224. Schwab M.E. Functions of Nogo proteins and their receptors in the nervous system. Nat. Rev. Neurosci. 2010, 11:799-811.
225. Schwab J.M., Guo L., Schluesener H.J. Spinal cord injury induces early and persistent lesional P2X4 receptor expression. J. Neuroimmunol. 2005, 163:185-189.
226. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
227. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., Jung S., Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
228. Shechter R., Raposo C., London A., Sagi I., Schwartz M. The glial scar-monocyte interplay: a pivotal resolution phase in spinal cord repair. PLoS One 2011, 6:e27969.
229. Shi C., Pamer E.G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 2011, 11:762-774.
230. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
231. Siegel R.M., Chan F.K., Chun H.J., Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 2000, 1:469-474.
232. Smith D.E. The biological paths of IL-1 family members IL-18 and IL-33. J. Leukoc. Biol. 2011, 89:383-392.
233. Smith D.E., Lipsky B.P., Russell C., Ketchem R.R., Kirchner J., Hensley K., Huang Y., Friedman W.J., Boissonneault V., Plante M.M., Rivest S., Sims J.E. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity 2009, 30:817-831.
234. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
235. Soulet D., Pare A., Coste J., Lacroix S. Automated filtering of intrinsic movement artifacts during two-photon intravital microscopy. PLoS One 2013, 8:e53942.
236. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S. Interleukin-6, a mental cytokine. Brain Res. Rev. 2011, 67:157-183.
237. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. 2007, 2:140-153.
238. Stirling D.P., Yong V.W. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J. Neurosci. Res. 2008, 86:1944-1958.
239. Stirling D.P., Liu S., Kubes P., Yong V.W. Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J. Neurosci. 2009, 29:753-764.
240. Stirling D.P., Cummins K., Mishra M., Teo W., Yong V.W., Stys P. Toll-like receptor 2-mediated alternative activation of microglia is protective after spinal cord injury. Brain 2014, 137:707-723.
241. Stirling D.P., Cummins K., Chen S.R., Stys P. Axoplasmic reticulum Ca release causes secondary degeneration of spinal axons. Ann. Neurol. 2014, 75:220-229.
242. Stoll G., Griffin J.W., Li C.Y., Trapp B.D. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J. Neurocytol. 1989, 18:671-683.
243. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
244. Tator C.H., Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 1991, 75:15-26.
245. Thawer S.G., Mawhinney L., Chadwick K., de Chickera S.N., Weaver L.C., Brown A., Dekaban G.A. Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the lys-egfp-ki mouse model. J. Neuroimmunol. 2013, 261:7-20.
246. Thomassen E., Bird T.A., Renshaw B.R., Kennedy M.K., Sims J.E. Binding of interleukin-18 to the interleukin-1 receptor homologous receptor IL-1Rrp1 leads to activation of signaling pathways similar to those used by interleukin-1. J. Interferon Cytokine Res. 1998, 18:1077-1088.
247. Thompson C.D., Zurko J.C., Hanna B.F., Hellenbrand D.J., Hanna A. The therapeutic role of interleukin-10 after spinal cord injury. J. Neurotrauma 2013, 30:1311-1324.
248. Thornton P., McColl B.W., Greenhalgh A., Denes A., Allan S.M., Rothwell N.J. Platelet interleukin-1alpha drives cerebrovascular inflammation. Blood 2010, 115:3632-3639.
249. Tibbetts M.D., Zheng L., Lenardo M.J. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 2003, 4:404-409.
250. Tsakiri N., Kimber I., Rothwell N.J., Pinteaux E. Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones. Mol. Cell. Neurosci. 2008, 38:259-265.
251. Tschopp J., Martinon F., Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 2003, 4:95-104.
252. Tsuda Y., Takahashi H., Kobayashi M., Hanafusa T., Herndon D.N., Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004, 21:215-226.
253. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
254. Vargas M.E., Barres B.A. Why is Wallerian degeneration in the CNS so slow?. Annu. Rev. Neurosci. 2007, 30:153-179.
255. Wells J.E., Rice T.K., Nuttall R.K., Edwards D.R., Zekki H., Rivest S., Yong V.W. An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice. J. Neurosci. 2003, 23:10107-10115.
256. Werman A., Werman-Venkert R., White R., Lee J.K., Werman B., Krelin Y., Voronov E., Dinarello C.A., Apte R.N. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2434-2439.
257. Woollard K.J., Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 2010, 7:77-86.
258. Wyss-Coray T., Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002, 35:419.
259. Yan P., Li Q., Kim G.M., Xu J., Hsu C.Y., Xu X.M. Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J. Neurotrauma 2001, 18:563-568.
260. Yan P., Liu N., Kim G.M., Xu J., Li Q., Hsu C.Y., Xu X.M. Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats. Exp. Neurol. 2003, 183:286-297.
261. Ye L., Huang Y., Zhao L., Li Y., Sun L., Zhou Y., Qian G., Zheng J.C. IL-1beta and TNF-alpha induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J. Neurochem. 2013, 125:897-908.
262. Yu W.R., Liu T., Fehlings T.K., Fehlings M.G. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur. J. Neurosci. 2009, 29:114-131.
263. Yune T.Y., Chang M.J., Kim S.J., Lee Y.B., Shin S.W., Rhim H., Kim Y.C., Shin M.L., Oh Y.J., Han C.T., Markelonis G.J., Oh T.H. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J. Neurotrauma 2003, 20:207-219.
264. Zheng Y., Humphry M., Maguire J.J., Bennett M.R., Clarke M.C. Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation. Immunity 2013, 38:285-295.
265. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. IL-10 promotes neuronal survival following spinal cord injury. Exp. Neurol. 2009, 220:183-190.
266. Zhou Z., Peng X., Insolera R., Fink D.J., Mata M. Interleukin-10 provides direct trophic support to neurons. J. Neurochem. 2009, 110:1617-1627.
267. Zhu W., London N.R., Gibson C.C., Davis C.T., Tong Z., Sorensen L.K., Shi D.S., Guo J., Smith M.C., Grossmann A.H., Thomas K.R., Li D.Y. Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature 2012, 492:252-255.
268. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.
269. Zong S., Zeng G., Wei B., Xiong C., Zhao Y. Beneficial effect of interleukin-1 receptor antagonist protein on spinal cord injury recovery in the rat. Inflammation 2012, 35:520-526.